Literature DB >> 8186548

Suppression of allogeneic reactivity in vitro by the syncytiotrophoblast membrane glycocalyx of the human term placenta is carbohydrate dependent.

P D Arkwright1, T W Rademacher, F Boutignon, R A Dwek, C W Redman.   

Abstract

Immunosuppressive factors isolated from trophoblast are known to block both innate and major histocompatibility complex (MHC)-dependent cell-mediated immune responses in vitro and, in some cases, in vivo. We investigated the biochemical nature of these factors, which is presently unknown. Immunosuppressive activity, assessed by inhibition of two-way MLR, was extracted from term syncytiotrophoblast microvilli using 3 M KCl. The activity resisted both extensive pronase digestion and heating to 90 degrees C for 1 h, demonstrating that intact membrane proteins were not required. Although purified protein-linked oligosaccharides released by hydrazinolysis from the syncytiotrophoblast membrane were themselves inactive, they blocked the immunosuppressive activity of the KCl extract. After pronase digestion, the activity could be fractionated by TSK 55S gel filtration, followed by C18 reverse-phase chromatography. Sequential exoglycosidase digestion of hydrazine-released sugars of the active fraction demonstrated that it contained neutral N-linked oligomannose and hybrid oligosaccharides, which normally make up < 3% of the total syncytiotrophoblast-derived protein glycan library. These glycopeptides of the active fraction were associated with membrane phospholipid micelles. The possible mechanism by which incompletely processed N-linked oligosaccharides expressed by a variety of syncytiotrophoblast membrane glycoproteins may block allogeneic reactivity when presented as polyvalent sugar groups is discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8186548     DOI: 10.1093/glycob/4.1.39

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  7 in total

1.  Maltooligosaccharides from JEG-3 trophoblast-like cells exhibit immunoregulatory properties.

Authors:  Aiping Zhu; Roberto Romero; Ji-Biao Huang; Andrea Clark; Howard R Petty
Journal:  Am J Reprod Immunol       Date:  2011-01       Impact factor: 3.886

2.  A primate subfamily of galectins expressed at the maternal-fetal interface that promote immune cell death.

Authors:  Nandor Gabor Than; Roberto Romero; Morris Goodman; Amy Weckle; Jun Xing; Zhong Dong; Yi Xu; Federica Tarquini; Andras Szilagyi; Peter Gal; Zhuocheng Hou; Adi L Tarca; Chong Jai Kim; Jung-Sun Kim; Saied Haidarian; Monica Uddin; Hans Bohn; Kurt Benirschke; Joaquin Santolaya-Forgas; Lawrence I Grossman; Offer Erez; Sonia S Hassan; Peter Zavodszky; Zoltan Papp; Derek E Wildman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-02       Impact factor: 11.205

3.  Preventive and therapeutic potential of placental extract in contact hypersensitivity.

Authors:  Youn Son Kim; Jang-June Park; Yukimi Sakoda; Yuming Zhao; Katsuya Hisamichi; Tai-Ichi Kaku; Koji Tamada
Journal:  Int Immunopharmacol       Date:  2010-07-07       Impact factor: 4.932

4.  Characterisation of syncytiotrophoblast vesicles in normal pregnancy and pre-eclampsia: expression of Flt-1 and endoglin.

Authors:  Dionne S Tannetta; Rebecca A Dragovic; Chris Gardiner; Christopher W Redman; Ian L Sargent
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

5.  The immunomodulatory role of syncytiotrophoblast microvesicles.

Authors:  Jennifer Southcombe; Dionne Tannetta; Christopher Redman; Ian Sargent
Journal:  PLoS One       Date:  2011-05-25       Impact factor: 3.240

Review 6.  Microparticles: markers and mediators of sepsis-induced microvascular dysfunction, immunosuppression, and AKI.

Authors:  Ana Carolina P Souza; Peter S T Yuen; Robert A Star
Journal:  Kidney Int       Date:  2015-02-18       Impact factor: 10.612

Review 7.  Extracellular vesicles and reproduction-promotion of successful pregnancy.

Authors:  Dionne Tannetta; Rebecca Dragovic; Zahraa Alyahyaei; Jennifer Southcombe
Journal:  Cell Mol Immunol       Date:  2014-06-23       Impact factor: 11.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.